Under the Amendment, Variational AI will not design, generate or deliver to any other party, compounds intended to meet the specific combination of potency, selectivity, drug-like properties and brain ...

Rakovina Therapeutics renegotiated its AI collaboration with Variational AI, securing kt-5000 exclusivity via future ...

Kia has launched a pilot remote-controlled PV5 electric van car-sharing service in Pangyo, South Korea, running through the ...

Studio AIM is preparing AIMMOVIE, an AI-native mid-form OTT platform, to address a gap in monetization for AI creators and a ...

The article titled, "A phase 2, randomized, placebo-controlled study to evaluate once-daily oral Travelan for the prevention of Travellers' Diarrhoea," describes clinical data previously announced to ...

Kia has launched Korea’s first car-sharing trial using remote vehicle operation, aiming to assess its commercial viability ...

Seoul shares plunged more than 3 percent Monday as a massive sell-off in technology stocks fueled by inflation concerns ...

Co-organized by Jeonnam Technopark and others, the event drew 532 on-site interviews and 15 immediate hires. Jeonnam ...

Rakovina Therapeutics Inc. ( RKV.V ), a biopharmaceutical company developing cancer therapies through AI-powered drug discovery, announced an amendment and extension to its research services agreement ...

Gov. Andy Beshear sent a letter to Brooke Rollins, the U.S. Secretary of Agriculture and to Kentucky’s congressional ...

Kia announced Friday it has launched Korea's first carsharing pilot using remote-driving technology, deploying its PV5 ...

Rakovina Therapeutics Inc. announced an amendment (the ?Amendment?) and extension to its research services agreement with Vancouver-based Variational AI Inc. (?Variational AI?). The new agreement will ...